Evidence map›Paper›PMID 23933188›Full record

ArticleCellular immunology

Helper T cells down-regulate CD4 expression upon chronic stimulation giving rise to double-negative T cells.

Inna V Grishkan, Achilles Ntranos, Peter A Calabresi, Anne R Gocke

Abstract read
In one paragraph

Article in Cellular immunology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 51 citations in OpenAlex.

  1. Persistent CD4Cellular immunology · 2026
    Article
  2. Article
  3. Increased CD95Frontiers in immunology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Blocking activation of CD4Clinical immunology (Orlando, Fla.) · 2023
    Article
  12. Article
  13. Review
  14. Article
  15. Role of T cells in ischemic acute kidney injury and repair.The Korean journal of internal medicine · 2022
    Review
  16. Review
  17. Tumor-Specific CD4Frontiers in immunology · 2022
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Inna V GrishkanDepartment of Neurology, The Johns Hopkins University School of Medicine, 600 North Wolfe Street, Baltimore, MD, USA.
Achilles Ntranos
Peter A Calabresi
Anne R Gocke
Johns Hopkins Medicine · USJohns Hopkins University · US

Funding

The Role of KV1.3 in Effector T cellsR01NS041435 · NINDS · UNIVERSITY OF MARYLAND BALTIMORE · PI CALABRESI, PETER A · 2000 to 2025
$5.8M
NINDS NIH HHS R01 NS041435
6 · The paper itself

Abstract

Double-negative T (DNT) cells are αβTCR(+)CD3(+)CD4(-)CD8(-)NK1.1(-) cells that constitute a small but significant proportion of the αβTCR(+) T cells. Their developmental pathway and pathological significance remain unclear. In the present study, we utilized chronic in vitro stimulation of CD4(+) T cells to mimic immune hyper-activation of autoimmune lymphoproliferative syndrome and systemic lupus erythematosus, conditions characterized by DNT cells accumulation. After approximately 4-5 rounds of stimulation, the CD3(+)CD4(-) population became apparent. These cells did not express CD8, NK1.1, γδTCR, or B220, exhibited a highly proliferative effector phenotype, and were dependent on T cell receptor (TCR) stimulation for survival. Moreover, CD3(+)CD4(-) cells expressed MHC class II-restricted αβTCR, indicative of their origin from a CD4(+) T cell population. The results presented herein illustrate a novel method of DNT cell generation in vitro and suggest that immune hyper-activation could also be implicated in the genesis of the disease-associated DNT cells in vivo.

Indexed as

AnimalsAutoimmune Lymphoproliferative SyndromeCD4-Positive T-LymphocytesCell ProliferationDown-RegulationFemaleFlow CytometryLupus Erythematosus, SystemicMaleMiceMice, Inbred C57BLMice, TransgenicPhenotypeReceptors, Antigen, T-Cell, alpha-betaT-Lymphocytes, Helper-InducerReceptors, Antigen, T-Cell, alpha-betaCD4 co-receptorDouble-negative T cellsHelper T cellsKv1.3

Identifiers

PMID23933188
PMCPMC3788052
OpenAlexW2038621474

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.